Glycemic Variability After SASI Versus Roux-en-Y Gastric Bypass
Sponsor: Hospitales Universitarios Virgen del Rocío • ClinicalTrials.gov ID: NCT07872397
Recruiting for Similar Conditions?
Sponsors are looking for patients like you. See if you qualify for compensated research studies.
Check Eligibility →Description
The GLUBARI trial is a prospective, randomized, single-center clinical study comparing two bariatric surgical procedures in adults with morbid obesity: Single Anastomosis Sleeve Ileal Bypass (SASI) and Roux-en-Y Gastric Bypass (RYGB). The main objective is to compare glycemic variability between the two procedures using continuous glucose monitoring. Participants will undergo continuous glucose monitoring for 7 days before surgery and again at 6 and 12 months after surgery. Secondary outcomes include hypoglycemic events, weight loss, resolution of obesity-related comorbidities, postoperative complications, gastroesophageal reflux, nutritional deficiencies, and quality of life. A total of 68 participants will be randomized in a 1:1 ratio to SASI or RYGB and followed for 12 months after surgery.
Interventions
-
Single Anastomosis Sleeve Ileal Bypass
(Procedure)
Bariatric surgical procedure consisting of sleeve gastrectomy with a single gastroileal anastomosis.
-
Roux-en-Y Gastric Bypass
(Procedure)
Bariatric surgical procedure consisting of gastric pouch creation with gastrojejunal and jejunojejunal anastomoses.
Eligibility criteria
Conditions
Locations
- Hospital Universitario Virgen del Rocío — Seville, Sevilla, Spain
Partner with Nurenyx
Showcase your study to thousands of motivated patients matching your criteria.
Learn MoreOfficial Source
Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
View Official Record